Stock listing

LSE:0IP1 Bastide Le Confort Medical SA Share Price

UK listing (LSE) of Bastide Le Confort Medical SA · home listing Euronext:BLC

Follow Bastide Le Confort Medical SA into a list and get an email when it puts out news.

Share price · LSE:0IP1

€19.20 EUR +0.91 (+5.0%)

Close on Oct 22, 2026

Day range
€19.20 – €19.20 EUROct 22, 2026
Volume
323 sharesOct 22, 2026
Market cap
€192.5M EURAt the close on Oct 22, 2026 · price × 10.02M shares outstanding
Bastide Le Confort Medical SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:BLC · Home€18.92 EUR+0.44 (+2.4%)14,669€19.20€19.48€18.24€18.48Close on Oct 22, 2026
LSE:0IP1€19.20 EUR+0.91 (+5.0%)323€19.20€19.20€19.20€18.29Close on Oct 22, 2026
Stuttgart:1DJ€18.06 EUR+0.02 (+0.1%)—€18.06€19.02€17.20€18.04Close on Oct 22, 2026
Frankfurt:1DJ€18.12 EUR+0.10 (+0.6%)—€18.92€18.92€18.12€18.02Close on Oct 22, 2026
Ticker
LSE:0IP1
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
LSE
Currency
EUR

What changed lately

Latest news

2026.10.08 BLCM - Actions et droits de vote au 30.09.2026

Oct 8, 2026

Revenue for 2025-2026, excluding the impact of the sale of EXPERF: EUR 526 million, exceeding the target 2025-2026 revenue as reported: EUR 483 million, up 7.6% Recurring operating margin target of around 9% confirmed

Sep 3, 2026

Completion of the disposal of New Medical Concept, the holding company of EXPERF Group, to Sapio Group

Jun 1, 2026

Strong momentum for the first nine months of the financial year: up 7.2% on an organic basis

May 13, 2026

2025-2026 half-year results

Mar 18, 2026

Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent growth momentum in home healthcare services: 9.2% / Accelerated growth in the Homecare business, up 6.5% // 2025-2026 targets confirmed

Feb 12, 2026

Organic growth of 8.3% in first-quarter 2025-2026: Sustained growth in home healthcare services, up 10.7% / Homecare business up 4.7%, driven by the healthcare institutions business (up 8.5%)

Nov 13, 2025

Rapport financier annuel au 30 juin 2025

Oct 31, 2025

2025-2026 financial calendar

Oct 28, 2025

2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses

Oct 22, 2025

All Bastide Le Confort Medical SA news

Decks

Bastide Le Confort Medical SA on 6ix

Sector
Health care
Industry
Health care services
News releases
9 in the last 12 months · 12 in all · newest Oct 8, 2026 · oldest 2025
Decks
3 decks · latest May 10, 2023

Where Bastide Le Confort Medical SA is listed

ListingExchangeCountryCurrency
Euronext:BLC · Home listingEuronextFranceEUR
LSE:0IP1 · This pageLSEUnited KingdomEUR
LS Exchange:907048LS ExchangeGermanyEUR
gettex:1DJgettexGermanyEUR
Lang & Schwarz:907048Lang & SchwarzGermanyEUR
Aquis:BLCPAquisUnited KingdomEUR
Aquis:BLCPAquisUnited KingdomEUR
Stuttgart:1DJStuttgartGermanyEUR
Dusseldorf:1DJDusseldorfGermanyEUR
Frankfurt:1DJFrankfurtGermanyEUR
Munich:1DJMunichGermanyEUR
Turquoise:BLCPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Bastide Le Confort Medical SA.